COMBINATION OF A BH4 ANTAGONIST AND A MTOR INHIBITOR FOR LUNG CANCER THERAPY
申请人:Emory University
公开号:EP3140275B1
公开(公告)日:2020-07-08
BH4 Antagonists and Methods Related Thereto
申请人:Emory University
公开号:US20170071896A1
公开(公告)日:2017-03-16
The disclosure relates to BH4 inhibitors and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.